background image

Paid Clinical Trials Chicago

Discover 65 paid clinical trials in Chicago, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
3

Observational Study

Recruiting

Sponsor:

physIQ, Inc.

Location:

Chicago IL, Montréal

Code:

NCT05237024

Conditions

Vaccine Reaction

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Accepted

Observational Study

Recruiting

Sponsor:

University of Chicago

Location:

Chicago IL

Code:

NCT06417762

Conditions

Misinformation

Influenza

COVID-19

Vaccine Hesitancy

Communication Research

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

Interventions

Science Communication Curriculum Cohort 1

Science communication curriculum Cohort 2

Science communication curriculum Cohort 3

Alisertib & Endocrine Therapy

Recruiting
PHASE2

Sponsor:

Puma Biotechnology, Inc.

Location:

Chicago IL, Maumee OH, St Louis MO, Columbus OHshow 25 more

Code:

NCT06369285

Conditions

Hormone Receptor Positive HER-2 Negative Breast Cancer

Metastatic Breast Cancer

Recurrent Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Alisertib

Endocrine therapy

TOS-358

Recruiting
PHASE1

Sponsor:

Totus Medicines

Location:

Chicago IL, Nashville TN, Fairfax VA, Philadelphia PAshow 3 more

Code:

NCT05683418

Conditions

Squamous Cell Carcinoma of Head and Neck

Endometrial Cancer

HR+/HER2-negative Breast Cancer

Bladder Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

TOS-358

RLY-2608 & Fulvestrant

Recruiting
PHASE1

Sponsor:

Relay Therapeutics, Inc.

Location:

Chicago IL, Madison WI, Indianapolis IN, Ann Arbor MIshow 15 more

Code:

NCT05216432

Conditions

PIK3CA Mutation

Solid Tumor, Adult

HER2-negative Breast Cancer

Breast Cancer

Metastatic Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

RLY-2608

Fulvestrant

Palbociclib 125mg

Ribociclib 400mg

Ribociclib 600mg

Interested in new vaccine trials?

Get alerts for new trials in your area by subscribing now

By submitting, you consent to the use of your personal details, including contact information and location, to respond to your request for information related to clinical trials, as outlined in the Privacy Policy. If at any time you want to discontinue receiving alerts, please click the Unsubscribe link in the email received.

TheraT® Vectors & Chemotherapy

Recruiting
PHASE1
PHASE2

Sponsor:

University of Chicago

Location:

Chicago IL

Code:

NCT05108870

Conditions

Human Papilloma Virus

HPV

HPV Positive Oropharyngeal Squamous Cell Carcinoma

Head and Neck Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

HB-201

HB-202

Carboplatin

Paclitaxel

Transoral Robotic Surgery

Alpelisib & Endocrine Therapy

Recruiting
PHASE2

Sponsor:

Marina N Sharifi

Location:

Chicago IL, Omaha NE, Hershey PA

Code:

NCT04762979

Conditions

Hormone Receptor Positive Breast Carcinoma

HER2-negative Breast Cancer

PIK3CA Mutant Metastatic Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Alpelisib

Fulvestrant

Aromatase inhibitor

CD40 Agonist, Flt3 Ligand, Chemotherapy

Recruiting
PHASE1

Sponsor:

University of Texas Southwestern Medical Center

Location:

Chicago IL, Baltimore MD, Chapel Hill NC, Dallas TXshow 1 more

Code:

NCT05029999

Conditions

HER2-negative Breast Cancer

Metastatic Breast Cancer

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

PLD Chemotherapy

CDX-1140

CDX-301

Liver Cancer Screening

Recruiting

Sponsor:

University of Texas Southwestern Medical Center

Location:

Chicago IL, Indianapolis IN, Ann Arbor MI, Detroit MIshow 11 more

Code:

NCT06084234

Conditions

Carcinoma, Hepatocellular

Liver Cancer

Liver Cirrhosis

Hepatitis B

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

GALAD

Liver Ultrasound with or without AFP

Neoadjuvant Agents

Recruiting
PHASE2

Sponsor:

QuantumLeap Healthcare Collaborative

Location:

Chicago IL, Maywood IL, Lansing MI, Rochester MNshow 20 more

Code:

NCT01042379

Conditions

Breast Neoplasms

Breast Cancer

Breast Tumors

Angiosarcoma

TNBC - Triple-Negative Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Standard Therapy

AMG 386 with or without Trastuzumab

AMG 479 (Ganitumab) plus Metformin

MK-2206 with or without Trastuzumab

AMG 386 and Trastuzumab

Chicago is a vital city for clinical research, offering a robust healthcare network and renowned medical research institutions. Major facilities such as The University of Chicago Medicine, Northwestern Medicine, and Rush University Medical Center are at the forefront of pioneering research across various fields, including cancer, cardiovascular health, and neurological disorders.

Why choose Chicago for clinical trials?

Common conditions studied in Chicago

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Chicago